70437-240 : Nerlynx 48.31 mg Oral Tablet
| NDC: | 70437-240 |
| Labeler: | Puma Biotechnology, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Nerlynx |
| Dosage Form: | Oral Tablet |
| Application #: | NDA208051 |
| Rev. Date: |
Appearance:
| Markings: | W104 |
| Shapes: |
Oval |
| Colors: |
 Red |
| Size (mm): | 11 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 70437-240-18: 1 BOTTLE IN 1 BOX (70437‑240‑18) > 180 TABLET IN 1 BOTTLE
- 70437-240-26: 1 BOTTLE IN 1 BOX (70437‑240‑26) > 126 TABLET IN 1 BOTTLE
- 70437-240-33: 1 BOTTLE IN 1 BOX (70437‑240‑33) > 133 TABLET IN 1 BOTTLE
Active Ingredients:
- Neratinib Maleate
Dosage Strength:
- 40 mg
Inactive Ingredients:
- Silicon Dioxide
- Mannitol
- Microcrystalline Cellulose
- Crospovidone
- Povidone
- Magnesium Stearate
- Water
- Polyvinyl Alcohol, Unspecified
- Titanium Dioxide
- Polyethylene Glycol, Unspecified
- Talc
- Ferric Oxide Red
Pharmaceutical Classes:
- Kinase Inhibitor [EPC]
- Kinase Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70436-227Next: 70441-0001 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.